Literature DB >> 8645839

Human granulocytic ehrlichiosis in Connecticut: report of a fatal case.

C J Hardalo1, V Quagliarello, J S Dumler.   

Abstract

We report a case of granulocytic ehrlichiosis in a 71-year-old man who presented with an acute febrile illness and subsequently developed multisystem organ dysfunction and sudden severe anemia with thrombocytopenia requiring intensive care, mechanical ventilation, hemodialysis, and transfusions. The diagnosis was suspected on the fifth hospital day after a peripheral blood smear was examined; intracytoplasmic inclusion bodies were present in granulocytes only. Results of serological tests of acute and convalescent sera confirmed the diagnosis of granulocytic ehrlichiosis. We discuss the features of this case that were similar to those of published case reports as well as the course and outcome of treatment. This, to our knowledge, represents to first documented case of human granulocytic ehrlichiosis to occur outside the Upper Midwest. Because of the possible epidemiological association of Ehrlichia species with the deer tick Ixodes scapularis (dammini), this case raises additional concern for clinicians and patients in regions where Lyme disease is endemic.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8645839     DOI: 10.1093/clinids/21.4.910

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  38 in total

1.  Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State.

Authors:  S J Wong; G S Brady; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data.

Authors:  F Scott Dahlgren; Kristen Nichols Heitman; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

3.  A human case of monocytic ehrlichiosis with adult respiratory distress syndrome in northern California.

Authors:  D J Vugia; E Holmberg; E M Steffe; M S Ascher; D Gallo
Journal:  West J Med       Date:  1996-06

Review 4.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

5.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

7.  Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome.

Authors:  Jacob W IJdo; Angel C Mueller
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients.

Authors:  Quan Lin; Ning Zhi; Norio Ohashi; Harold W Horowitz; Maria E Aguero-Rosenfeld; John Raffalli; Gary P Wormser; Yasuko Rikihisa
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis.

Authors:  M Bayard-Mc Neeley; A Bansal; I Chowdhury; G Girao; C B Small; K Seiter; J Nelson; D Liveris; I Schwartz; D F Mc Neeley; G P Wormser; M E Aguero-Rosenfeld
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

10.  Mechanisms of variable p44 expression by Anaplasma phagocytophilum.

Authors:  Quan Lin; Yasuko Rikihisa; Norio Ohashi; Ning Zhi
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.